Ampyra

Ampyra
Generic Name: dalfampridine (dal FAM pri deen)
Brand Names: Ampyra
Company: Acorda
FDA Approved: January 2010
Specific Treatments: walking in patients with multiple sclerosisAmprya is rated 8.0/10

Ampyra (dalfampridine) is a potassium channel blocker.

Ampyra dosing information
Usual Adult Dose for Multiple Sclerosis:
Maximum dose: 10 mg orally every 12 hours

Comments:
-This drug may be taken with or without food.
-Tablets should be swallowed whole, and not divided, crushed, chewed, or dissolved.
-Patients should not take double or extra doses if a dose is missed.

Use: To improve walking in adult patients with multiple sclerosis (MS) demonstrated by an increase in walking speed

It is not known if Ampyra is safe or effective in children less than 18 years old.

Important Information
Ampyra can cause a seizure (convulsions), even if you have never had one before. Taking too much dalfampridine may increase your risk of seizure. Kidney problems may also increase your risk. Your kidney function may need to be tested before you start taking this medicine.

Stop taking Ampyra and call your doctor at once if you a seizure, pain or burning when you urinate, problems with your balance, numbness or tingly feeling, or a relapse of your MS symptoms.

High doses of dalfampridine may increase your risk of seizure. Do not take more than 2 tablets in a 24-hour period. Do not use a tablet that has been broken or crushed. A broken tablet can release too much of the drug at one time.